Navigation Links
Kaiser Permanente Data Provides Strong Evidence for Continued Value of Combined Pap and HPV Testing
Date:3/24/2009

r's previously published protocol, this group of women would be scheduled for re-testing in 12 months to monitor the persistence of HPV infection. The study authors concluded, "In a general screening population, concerns about excessive HPV test positives among women aged 30 years and older are not borne out."

Investigators also revealed that among those women who tested positive for high-risk HPV infection with the digene HPV Test, patients in the age segments of 30-34 years (10.82 percent) and 35-39 years (8.03 percent) had the highest infection rates and also were the groups with the highest prevalence of CIN2/3, thus reinforcing the clinical benefit of reserving routine HPV testing for women age 30 and higher.

"These study results illustrate the benefits to large health systems of combined screening with the digene HPV Test and a Pap for all women age 30 and older, and dispels the notion that excessive numbers of women would require increased surveillance and follow-up when HPV testing is implemented," said Dr. Jim Godsey, Senior Vice President Research & Development North America for QIAGEN. "Some doctors have exercised caution using HPV testing out of now-disproven concern that they would have a lot of patients with Pap normal/HPV positive test results who would require counseling and follow-up. This study clearly demonstrates that this is not the case, and importantly shows cotest outcome rates within the very large and diverse patient population that Kaiser serves. This is good news to the clinical community who may have been overly anxious about the management of a large number of HPV positive, Pap normal test results. In fact, by identifying the women who test positive for infection with one of the cancer causing types of HPV -- and who are hence at greater risk of developing cervical disease -- clinicians can more effectively direct treatment and follow-up, potentially detecting more early stage disease
'/>"/>

SOURCE QIAGEN
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Kaiser Permanente Pasadena Marathon is Ready and Set to Go Sunday
2. Kaiser Permanente Ranked No. 7 on DiversityIncs Top 50 Companies for Diversity(R)
3. Pasadena Marathon Presented By Kaiser Permanente Hails Partnership With Tiffany & Co.
4. Kaiser Permanente Identifies Key Elements in Successful Health Care Information Technology Implementation
5. Kaiser Permanente Recognized as Best Place for Diverse Managers
6. Kidney Disease Increases the Risk of Stroke in Patients With the Most Common Type of Heart Arrhythmia, According to Kaiser Permanente Study
7. Kaiser Permanente Study Finds Drinking Wine May Lower Risk of Barretts Esophagus, Precursor to Nations Fastest Growing Cancer, Esophageal Cancer
8. Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Report Fourth Quarter and Fiscal-Year 2008 Results
9. Kaiser Permanente Approves $43 Million in Community Benefit Grants in Fourth Quarter 2008
10. Kaiser Permanente Provides Seed Funding to the Institute for Healthcare Improvements New Open School for Health Professions
11. Kaiser Family Foundation Partners With Media Around The Globe to Address HIV/AIDS

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... Firm uses Staten Island courtroom to r...endants were 100% responsible for client’s a...s Nexis) November 30, 2009 -- A Staten Island, N.Y... union paperhanger who was injured at a New York C...mondi v. J.T. Magen Construction Company et al (In...
(Date:11/30/2009)...ICAGO, Nov. 30 Three decades ago, ...being swallowed by children, prompting a switch by...ented today at the annual meeting of the Radiologi... new tabs are still potentially unsafe. ,, "One...rage can construction in the U.S. was to eliminate...
(Date:11/30/2009)..., RALEIGH, N.C., Nov. 30 Raleig...iates have launched a new plan to educate the comm...s many benefits. ,, Through a series of free ed...amson is taking a lead role in educating the publi..., The series of sedation dental care educational...
(Date:11/30/2009)...arge proportion of patients who undergo abdominal/...d and unnecessary additional image acquisition res...cording to a study presented today at the annual m...a (RSNA). , "It is the responsibility of all phy... that the dosage is as low as reasonably achievabl...
(Date:11/29/2009)...on deaths from cancer in Europe show a steady decl... 2000-2004. Deaths from all cancers in the Europea...e percent in men and eight percent in women, with ... In a study published online in the cancer journa...ber), researchers found that there was an average ...
Breaking Medicine News(10 mins):Health News:Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident 2Health News:Beverage Can Stay-Tabs Pose Swallowing Risk 2Health News:Raleigh Dentist Dr. Robert Williamson to Educate Patients About Sedation Dentistry 2Health News:Unindicated CT series result in unnecessary radiation exposure for patients 2Health News:Unindicated CT series result in unnecessary radiation exposure for patients 3Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 2Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 3Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 4Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 5
...-Vision Inc. (Nasdaq: LCAV ), a leading provider...ik Plus (R) brand, today announced its affiliation... that will make laser vision correction more affor... LCA-Vision,s National Lasik Network. , , LCA-Vis...
...insurer scheme that shifts medical costs to physic... The American Medical Association (AMA) and sever...al Society of New Jersey, joined with individual p...cally under-reimburse physicians. , , (Logo: htt...
.... 10 /PRNewswire-Asia/ -- WuXi AppTec (NYSE: WX ...ical device research and,development outsourcing c...nced it had recently held a successful 2009 suppli...together to create a brilliant,2009," assembled 11...
... For the growing number of patients considering su...isions they face is the choice between silicone or...geon offers his views on silicone breast implants,... (Vocus) February 10, 2009 -- In 2006, after...
... All Allied Health Schools helps students capitali...py. , Seattle, WA (PRWEB)...nounces the launch of their latest resource center...w.allalliedhealthschools.com/faqs/occupational-the...
... Supplemental insurance can be option to fill gaps... , Chicago, IL (PRWEB) Fe...mpleted their annual benefit enrollment period, C...ial gaps in coverage due to changes in their emplo...
Other Medicine News:Health News:LCA-Vision's National Lasik Network Named as U.S. Provider for National Vision Administrators 2Health News:LCA-Vision's National Lasik Network Named as U.S. Provider for National Vision Administrators 3Health News:LCA-Vision's National Lasik Network Named as U.S. Provider for National Vision Administrators 4Health News:AMA Announces Physician Class-Actions Against Aetna and CIGNA 2Health News:WuXi AppTec Successfully Holds Its 2009 Supplier Conference in Shanghai 2Health News:WuXi AppTec Successfully Holds Its 2009 Supplier Conference in Shanghai 3Health News:Two Years after FDA Approves Silicone Breast Implants, Atlanta-area Cosmetic Plastic Surgeon Dr. Tom Lintner Discusses Their Safety 2Health News:Two Years after FDA Approves Silicone Breast Implants, Atlanta-area Cosmetic Plastic Surgeon Dr. Tom Lintner Discusses Their Safety 3Health News:New Occupational Therapy School and Career Resource on All Allied Health Schools 2Health News:New Occupational Therapy School and Career Resource on All Allied Health Schools 3Health News:Leading Supplemental Insurer Recommends Insurance Review Following Annual Benefit Enrollment Period 2Health News:Leading Supplemental Insurer Recommends Insurance Review Following Annual Benefit Enrollment Period 3
(Date:11/30/2009)..., , RICHMOND, Va., Nov. 30 /PRNewswire/ -...icense with sanofi-aventis U.S. for a novel epinep...ory. Under the license, sanofi-aventis U.S. shall ...tion. Intelliject will be responsible for the on-g... approval and has retained certain co-promotion ri...
(Date:11/30/2009)..., , ATLANTA, G...College of,Direct Support (CDS), an internet-based...anaged in partnership by MC Strategies/Elsevier an...ining Center, announced today that,its second Disa...is now,available for administrators and learners t...
(Date:11/29/2009)..., , CHICAGO, Nov. 30 Middl...physical activity may be unknowingly causing damag...eoarthritis, according to a study presented today ...of North America (RSNA). ,, "Our data suggest t...y be at greater risk for developing knee abnormali...
Breaking Medicine Technology:Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 2Intelliject, Inc. Enters Into Licensing Agreement with sanofi-aventis for U.S./Canada Rights to Novel Epinephrine Auto-injector 3Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering 2Cerebral Palsy Course Strengthens CDS Curriculum as Second Disability Intensive Course Offering 3Too Much Physical Activity May Lead to Arthritis 2Too Much Physical Activity May Lead to Arthritis 3Female Supervisors More Likely to Be Sexually Harassed 54300 1Female Supervisors More Likely to Be Sexually Harassed 54300 2Female Supervisors More Likely to Be Sexually Harassed 54300 3September is Prostate Cancer Awareness Month 54295 1September is Prostate Cancer Awareness Month 54295 2Nfocus Neuromedical Obtains CE Approval for New Vascular Reconstruction Device 54292 1Nfocus Neuromedical Obtains CE Approval for New Vascular Reconstruction Device 54292 2
...il 29 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA... clinical trial of AZ-007 (Staccato(R) zaleplon). ...veloped for the treatment of insomnia,patients who...s who awake,in the middle of the night and have di... product candidate using our single-dose Staccato,...
...and multi-lesion clinical trial data to be pre..., May 13, MENLO PARK, Calif., April 28 XTENT, In...ts for the first quarter ended,March 31, 2008., T...r $0.54 per share,for the first quarter of 2008, c...r share, for the first quarter of 2007. The compan...
Other Medicine Technology:Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon) 2Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon) 3Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon) 4XTENT Announces First Quarter 2008 Financial Results 2XTENT Announces First Quarter 2008 Financial Results 3XTENT Announces First Quarter 2008 Financial Results 4XTENT Announces First Quarter 2008 Financial Results 5
Safeguard
...alant has been shown to be a highly effective adju...ucible concentrations of fibrinogen and thrombin, ...e of the coagulation cascade to produce a biocompa...nnective tissue like a natural plasma clot and sto...
...er is inserted into the subclavian or jugular vein...Line incorporates two proprietary, MocroTherm ball...line flowing within a closed-loop design, enabling.... The Cool Line combines two important patient ca...
Fortius
Medicine Products: